InsidersTradesSigma
Browse the full record of transactions filed by Moran Sean F., Chief Financial Officer. Officer active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 2 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €8k. History available since 10 March 2022. The latest transaction was disclosed on 16 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Sean F. Moran is the Chief Financial Officer of Corbus Pharmaceuticals Holdings, Inc. He oversees the financial operations of the company, including financial planning and reporting. Corbus Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing treatments for rare diseases.